Myeloproliferative Disorders: Clinical Trials

1 trial for Myeloproliferative Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Suspended 1

Follow Myeloproliferative Disorders: new trials by email Literature Review of Myeloproliferative Disorders trials Research Report on Myeloproliferative Disorders

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+
Compound realgar natural indigo Tablet, placebo - Chronic Myelogenous Leukemia
Phase 3SuspendedJunmin Li6802012-11-012018-04-25

Narrower conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Junmin Li (1)

Countries

China (1)

Top investigators

Saijuan Chen, M.D. (1)